Signal transducer and activator of transcription 1, 3, and 5 (STAT1/3/5)

The Signal Transducer and Activator of Transcription (STAT) proteins, specifically STAT1, STAT3, and STAT5, are key transcription factors in the JAK-STAT signaling pathway that regulate gene expression in response to cytokines and growth factors [10, 15]. STAT3 and STAT5 are frequently overactivated in many human cancers, where they function as oncogenes by promoting cell survival, proliferation, and angiogenesis while suppressing anti-tumor immune responses [3, 6, 9]. In contrast, STAT1 often acts as a tumor suppressor by mediating pro-apoptotic and anti-proliferative signals, although it can also contribute to therapy resistance in certain contexts [2, 7, 20]. These proteins are significant therapeutic targets, with drug development focusing on small-molecule inhibitors of their SH2 domains to prevent dimerization and nuclear translocation, as well as newer modalities like PROTACs for targeted degradation [9, 16, 19]. However, the high structural homology between STAT family members poses a challenge for achieving isoform selectivity [16, 18]. Clinical development has been hampered by safety concerns such as peripheral neuropathy and lactic acidosis [16, 18]. Beyond oncology, these proteins play vital roles in inflammation, autoimmune diseases, and the immune response to pathogens [10, 18, 21].

Other names

STAT1/3/5STAT family proteins (1, 3, 5)Signal transducers and activators of transcription 1, 3, and 5

Inhibition of STAT phosphorylation, dimerization, nuclear translocation, and DNA binding, or targeted protein degradation via PROTACs.